Allergy, Days Absent From Daycare, Gastrointestinal Infections, Respiratory Tract Infections
Conditions
Keywords
Infections, Allergy, Immune function, Microbiota, Infant
Brief summary
The aim of the intervention is to examine the effect of a combination of the two bacterial strains BB-12 and LGG, provided for 6 month, on the prevalence of infections and allergic manifestations in small children, and how a combination of BB-12 and LGG affects the immune system, gastrointestinal tract and the microbiota. Children are enrolled during 2 winter seasons.
Interventions
Combination of two probiotics (2 \* 10\^9 cfu/day) or probiotics for 6 months
Placebo for 6 months
Sponsors
Study design
Eligibility
Inclusion criteria
* Expected to start daycare between the age of 8-14 month * Intervention start 0 days to 12 weeks before starting daycare * Expected to start daycare from september to february (both month included) * Single born
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of days absent from daycare due to respiratory and gastrointestinal infections | up to 6 month | Recorded weekly by the parents using web-based questionnaires |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Antibiotic use | Up to 6 month | Number of treatments with antibiotics during the intervention period Recorded weekly by the parents using web-based questionnaires |
| Parental absence from work due to illness of the child | Up to 6 month | Number of days a parent is absent from work due to illness of the child (infections and other illnesses, respectively) Recorded by the parents weekly using web-based questionnaires |
| Medical visits | Up to 6 month | Number of visits to a doctor due to infections and other illnesses, respectively. Recorded by the parents using web-based questionnaires |
| Change from baseline in Thymus size | At baseline and after 6 mo (end of intervention) | Change in thymic size during intervention period will be evaluated using ultrasound |
| Acute upper respiratory tract infections | Up to 6 month | Number of days with acute upper respiratory tract infections (URTI); Number of children with at least 1 episode of URTI; Number of children with at least 3 episodes of URTI; Number of URTI episodes/child/year; Duration of URTI episodes (days); Additionally,symptoms of cold (defined as 2 days with runny/stuffy nose or cough) Recorded by the parents daily/weekly using web-based questionnaires. |
| Acute lower respiratory infections | Up to 6 month | Number of children with at least 1 episode of a lower respiratory tract infection (LRTI). LRTI include bronchitis and pneumonia Recorded by the parents weekly using web-based questionnaires. |
| Gastrointestinal infections | Up to 6 month | Number of children with at least 1 episode of diarrhea; Duration of episodes with diarrhea(days); Number of episodes/child/year with diarrhea; Number of days with vomiting. Recorded by the parents daily using web-based questionnaires |
| Fever | Up to 6 month | Number of days with fever Recorded by the parents using web-based questionnaires |
| Allergies | Up to 6 month | Number of children developing allergies during the intervention period (asthma, allergic rhinitis, atopic dermatitis, food allergies); Age for diagnosis of allergies; Use of medication due to allergies. Recorded by the parents using web-based questionnaires |
| Absence from day care due to illness other than infections | Up to 6 month | Number of days the child is absent from day care due to illness, which is not due to infections. Recorded by the parents weekly using web-based questionnaires |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in Biological markers of allergy | At baseline and after 6 mo | analysis of biological samples investigating the effect on allergy by biological markers at baseline and at 6 mo |
| Change from baseline in biological markers for the immune system | At baseline and after 6 mo | Analysis of biological material investigating the effect on the immune system by biological markers . |
| Change from baseline in biological markers for gastro-intestinal tract | At baseline and after 6 mo | Analysis of biological material investigating the effect on the gastrointestinal tract. |
Countries
Denmark